Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the supplemental New Drug Application for ORPATHYS ® (savolitinib) has been granted approval by the China National Medical ...
IRFs. During the December 2024 meeting, MedPAC commissioners discussed recommending a 7% reduction to fiscal year (FY) 2026 IRF PPS payments. AHA disagrees with this draft recommendation and instead ...
Hansa Biopharma AB, "Hansa" or the "Company" (Nasdaq Stockholm: HNSA), today announced that management will attend the 43rd Annual J.P. Morgan Healthcare Conference. If you are interested in a meeting ...
ReOrbit, a leading provider of software-enabled satellites for secure communications, announced the signing of a Memorandum of Understanding (MoU) with Ananth Technologies, a leading aerospace and ...